Alternatives to hormone replacement for menopause

Alternative Therapies in Health and Medicine

Volumn 2, Issue 2, 1996, Pages 34-39

  Sofia, Virginia M ^a,b,c,d  

^a Breast Cancer Action Group   (United States)

^b Saybrook Institute

^c InnoVision Communications ^*  (United States)

^d INNOVISION COMMUNICATIONS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST TUMOR; DIET SUPPLEMENTATION; ESTROGEN THERAPY; FEMALE; HEART DISEASE; HUMAN; MEDICINAL PLANT; MENOPAUSE; OSTEOPOROSIS; REVIEW;

BREAST NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; FEMALE; FOOD, FORTIFIED; HEART DISEASES; HUMANS; MENOPAUSE; OSTEOPOROSIS; PLANTS, MEDICINAL;

EID: 0030095037     PISSN: 10786791     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Wilson RA. Feminine Forever. New York, NY: Evans and Company; 1966:132-133.
2. Pearson C, Allina A, Fugh-Berman A, et al. Taking Hormones and Women's Health: Choices, Risks and Benefits. Washington, DC: National Women's Health Network; 1995:9.
3. Kennedy DL, Baum C, Forbes MB. Non-contraceptive estrogens and progestins: use patterns over time. Obstet Gynecol. 1985;65(3):441-446.
4. Ito D. Without Estrogen: Natural Remedies for Menopause and Beyond. New York, NY: Carol Southern; 1994:6.
5. Zones, JS. National Women's Heath Network Member Letter, June 1995.
6. Mazade L, Park G, eds. The Menopause, Hormone Therapy, and Women's Health. Washington, DC: US Government Printing Office. US Congress, Office of Technology Assessment; 1992.
7. Colditz GA, Hankinson SE, Hunter DJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med. 1995;332(24):1589-1593.
8. Rinzler CA. Estrogen and Breast Cancer: A Warning to Women. New York, NY: Macmillan; 1993:153.
9. Belchetz P. Hormonal treatment of postmenopausal women. N Engl J Med. 1994;330(15):1062-1070.
10. Miller VT, Barnabei V, Kessler C, et al. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in post menopausal women. JAMA. 1995;273(3):199-208.
11. Colditz GA, Stampfer MJ, Willett WC, Hennekens CH, Rosner B, Speizer FE. Prospective study of estrogen replacement therapy and risk of breast cancer in postmenopausal women. JAMA. 1990;264(20):2648-2653.
12. Merz, B. HRT and Breast Cancer Risk. Harv Womens Health Watch. 1995;2(12):1.
13. Ewertz M. Influence of non-contraceptive exogenous and endogenous sex hormones on breast cancer risk in Denmark. Int J Cancer. 1988;42:832-838.
14. Bergkvist L, Adami H-O, Persson I, Hover R, Schairer C. The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med. 1989;321:293-297.
15. Hunt K, Vessey M, McPherson K, Coleman M. Long-term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy. Br J Obstet Gynaecol. 1987;94:620-635.
16. Gambrell RD Jr, Maier RC, Sanders BI. Decreased incidence of breast cancer in postmenopausal estrogen-progestogen users. Obstet Gynecol. 1983;62:435-443.
17. Steinberg KK, Thacker SB, Smith ST, et al. A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA. 1991;265(15):1985-1990.
18. Ross RK, Paganini-Hill A, Mack TM, Arthur M, Henderson BE. Menopausal oestrogen therapy and protection from death from ischemic heart disease. Lancet. 1981;1:858-860.
19. Hemminki E, Silivo S. A renew of postmenopausal hormone therapy recommendations: potential for selection bias. Obstet Gynecol. 1993;82:1021-1028.
20. Rozenberg S, Gevers R, Peretz A, Vandromme J, Robyn C, Ham H. Decrease of bone mineral density during estrogen substitution therapy. Maturitas. 1993;17(3):205-210.
21. Weed S. Menopausal Years. New York, NY: Ash Tree Publishing; 1992:19-20.
22. Shangold M. Exercise in the menopausal woman. Obstet Gynecol. 1990;75(suppl to No. 4):53S-57S.
23. Appleton N. Healthy Bones: What You Should Know About Osteoporosis. New York, NY: Avery Publishing Group; 1991:84-88.
24. Lark SM. The Estrogen Decision: A Self-Help Program. Los Altos, Calif: Westchester Publishing; 1994:140.
25. Lock M. Contested meanings of menopause. Lancet. 1991;337:1270-1272.
26. Cassidy A, Bingham S, Setchell KD. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr. 1994;60(3):333-340.
27. Colbin A. The Book of Whole Meals. New York, NY: Ballantine Books; 1983.
28. Colbin A. The Natural Gourmet. New York, NY: Ballantine Books; 1989.
29. Michell K. Practically Macrobiotic. Rochester, Vt: Healing Arts Press; 1988.
30. Hornig D, Strolz F. Recommended dietary allowance: support for recent research. J Nutr Sci Vitaminol. 1992(special issue):173-176.
31. Machlin LF. Critical assessment of the epidemiological data concerning the impact of antioxidant nutrients on cancer and cardiovascular disease. Crit Rev Food Sci Nutr. 1995;35(1,2):41-50. Review.
32. Ojeda L. Menopause Without Medicine. Alameda, Calif: Hunter House; 1995.
33. Renaud S, McGregor L. Essential fatty acids and the platelet membrane in relations to aggregation. Ann Nutr Aliment. 1980;34(2):265.
34. Vles RO. Essential fatty acids in cardiovascular physiopathology. Ann Nutr Aliment. 1980;34(2):255.
35. Murray MT. Natural Alternatives to Over-the-Counter and Prescription Drugs. New York, NY: William Morrow; 1994.
36. Brown E, Walker L. Breezing Through the Change: Managing Menopause Naturally. Berkeley, Calif: Frog; 1994.
37. Yoshiro K. The physiological actions of tang-kuei and cnidium. Bull Oriental Heal Arts Inst USA. 1985;10:269-278.
38. Shibata S, Tanaka O, Shoji J, Saito H. Chemistry and pharmacology of panax. Econ Med Plant Res. 1985;1:217-284.
39. Hallstrom C, Fulder S, Carruthers M. Effect of ginseng on the performance of nurses on night duty. Comp Med East West. 1982;6:277-282.
40. D'Angelo L, Grimaldi R, Caravaggh M. A double-blind, placebo-controlled clinical study on the effect of a standardized ginseng extract on psychomotor performance in healthy volunteers. J Ethnopharmacol. 1986;16:15-22.
41. Lee JR. Natural Progesterone: The Multiple Roles of a Remarkable Hormone. Sebastapol, Calif: BLL Publishing; 1993.
42. Chang K-J, Lee TTY, Linares-Cruz G, Fournier S, de Lingniéres B. Influences of percutaneous administration of estradiol and progesterone on human breast epithelial cell cycle in vivo. Fertil Steril. 1995;63(4):785-791.
43. Morris K, Ungar S. Natural progesterone surpasses provera. Womens Health Forum. 1995;(4):1-2.
44. Pierpaoli W, Regelson W. The Melatonin Miracle. New York, NY: Simon and Schusten 1995.
45. Cowley G, reviewer. Melatonin. Newsweek. August 7, 1995:46-49. Review of: Pierpaoli W, Regelson W. The Melatonin Miracle.
46. Cowley G, reviewer. Melatonin. Newsweek. August 7, 1995:46-49. Review of: Pierpaoli W, Regelson W. The Melatonin Miracle.
47. Bhatavdekar JM, Petal DD, Shah NG, et al. Endocrine status in stage II vs advanced premenopausal and postmenopausal breast cancer patients. Neoplasma. 1992;39(1): 39-42.